These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20420453)

  • 41. Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin.
    Thaysen-Andersen M; Jørgensen SB; Wilhelmsen ES; Petersen JW; Højrup P
    Vaccine; 2007 Mar; 25(12):2213-27. PubMed ID: 17240009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural characterization by tandem mass spectrometry of the posttranslational polyglycylation of tubulin.
    Vinh J; Langridge JI; Bré MH; Levilliers N; Redeker V; Loyaux D; Rossier J
    Biochemistry; 1999 Mar; 38(10):3133-9. PubMed ID: 10074368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of diethylpyrocarbonate-modified amino acid residues in alpha 1-acid glycoprotein by high-performance liquid chromatography electrospray ionization-mass spectrometry and matrix-assisted laser desorption/ionization time-of-flight-mass spectrometry.
    Dage JL; Sun H; Halsall HB
    Anal Biochem; 1998 Mar; 257(2):176-85. PubMed ID: 9514787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conformation and ion-channeling activity of a 27-residue peptide modeled on the single-transmembrane segment of the IsK (minK) protein.
    Aggeli A; Bannister ML; Bell M; Boden N; Findlay JB; Hunter M; Knowles PF; Yang JC
    Biochemistry; 1998 Jun; 37(22):8121-31. PubMed ID: 9609707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Supramolecular bidentate ligands by metal-directed in situ formation of antiparallel beta-sheet structures and application in asymmetric catalysis.
    Laungani AC; Slattery JM; Krossing I; Breit B
    Chemistry; 2008; 14(15):4488-502. PubMed ID: 18449870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlling peptide structure with coordination chemistry: robust and reversible peptide-dirhodium ligation.
    Zaykov AN; MacKenzie KR; Ball ZT
    Chemistry; 2009 Sep; 15(36):8961-5. PubMed ID: 19637261
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of a combination of isotopically coded cross-linkers and isotopically coded N-terminal modification reagents for selective identification of inter-peptide crosslinks.
    Petrotchenko EV; Serpa JJ; Borchers CH
    Anal Chem; 2010 Feb; 82(3):817-23. PubMed ID: 20050626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The specific isolation of C-terminal peptides of proteins through a transamination reaction and its advantage for introducing functional groups into the peptide.
    Sonomura K; Kuyama H; Matsuo E; Tsunasawa S; Nishimura O
    Rapid Commun Mass Spectrom; 2009 Mar; 23(5):611-8. PubMed ID: 19165755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides.
    Waksman G; Kominos D; Robertson SC; Pant N; Baltimore D; Birge RB; Cowburn D; Hanafusa H; Mayer BJ; Overduin M; Resh MD; Rios CB; Silverman L; Kuriyan J
    Nature; 1992 Aug; 358(6388):646-53. PubMed ID: 1379696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of degradation products formed during performic oxidation of peptides and proteins by high-performance liquid chromatography with matrix-assisted laser desorption/ionization and tandem mass spectrometry.
    Dai J; Zhang Y; Wang J; Li X; Lu Z; Cai Y; Qian X
    Rapid Commun Mass Spectrom; 2005; 19(9):1130-8. PubMed ID: 15799070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequit: software for de novo peptide sequencing by matrix-assisted laser desorption/ionization post-source decay mass spectrometry.
    Demine R; Walden P
    Rapid Commun Mass Spectrom; 2004; 18(8):907-13. PubMed ID: 15095361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acetone precipitation of proteins and the modification of peptides.
    Simpson DM; Beynon RJ
    J Proteome Res; 2010 Jan; 9(1):444-50. PubMed ID: 20000691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix-assisted laser desorption ionization mass spectrometry: applications in peptide and protein characterization.
    Zaluzec EJ; Gage DA; Watson JT
    Protein Expr Purif; 1995 Apr; 6(2):109-23. PubMed ID: 7606158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elongating modified conserved peptides eliminates their immunogenicity and protective efficacy against P. falciparum malaria.
    Espejo F; Bermúdez A; Vanegas M; Rivera Z; Torres E; Salazar LM; Patarroyo ME
    J Struct Biol; 2005 Jun; 150(3):245-58. PubMed ID: 15890273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mass spectrometric strategy for primary structure determination of N-terminally blocked peptides.
    Huang RH; Wang DC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(1):167-72. PubMed ID: 15026010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Site-selective modification of peptides using rhodium and palladium catalysis: complementary electrophilic and nucleophilic arylation.
    Chapman CJ; Matsuno A; Frost CG; Willis MC
    Chem Commun (Camb); 2007 Oct; (38):3903-5. PubMed ID: 17896027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping.
    Carven GJ; Stern LJ
    Biochemistry; 2005 Oct; 44(42):13625-37. PubMed ID: 16229453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
    Yamazaki T; Nunami K; Goodman M
    Biopolymers; 1991 Nov; 31(13):1513-28. PubMed ID: 1814501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies of asymmetric styrene cyclopropanation with a rhodium(II) metallopeptide catalyst developed with a high-throughput screen.
    Sambasivan R; Ball ZT
    Chirality; 2013 Sep; 25(9):493-7. PubMed ID: 23749505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rhodium(II) metallopeptide catalyst design enables fine control in selective functionalization of natural SH3 domains.
    Vohidov F; Coughlin JM; Ball ZT
    Angew Chem Int Ed Engl; 2015 Apr; 54(15):4587-91. PubMed ID: 25688989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.